Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899028 · ClinicalTrials.gov registry record
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 689
- Enrollment target
NCT00899028: Completed study, sponsored by Vanderbilt University Medical Center.
NCT00899028 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 689 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00899028 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 689 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of tissue, blood, sputum, and urine from patients with lung cancer and from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at biomarkers for lung cancer using tissue samples from patients with lung cancer and from healthy participants.
Interventions
- GENETIC gene expression analysis
- GENETIC microarray analysis
- GENETIC protein expression analysis
- GENETIC fluorescence in situ hybridization
- GENETIC comparative genomic hybridization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 689 participants |
| Start Date | 2001-05 |
| Est. Completion | 2016-08 |
What the finished NCT00899028 record still lists
NCT00899028 is an observational study that tracks outcomes without assigning an intervention. The registered 689 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT00899028 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00899028 about?
NCT00899028 is a clinical study titled "Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants". RATIONALE: Studying samples of tissue, blood, sputum, and urine from patients with lung cancer and from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at biomarkers...
What is the current status of trial NCT00899028?
This trial is currently completed. The enrollment target is 689 participants. The study started on 2001-05. Estimated completion is 2016-08.
What interventions are being tested in trial NCT00899028?
The interventions under investigation include: gene expression analysis (GENETIC), microarray analysis (GENETIC), protein expression analysis (GENETIC), fluorescence in situ hybridization (GENETIC), comparative genomic hybridization (GENETIC).
Who is sponsoring clinical trial NCT00899028?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00532051 · 690 participants
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
- NCT05184335 · 690 participants · Phase 3
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- NCT07221149 · 690 participants · Phase 2
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- NCT05750654 · 688 participants · NA
Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia